Crinetics Pharmaceuticals (CRNX) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to -$1.1 billion.
- Crinetics Pharmaceuticals' Enterprise Value fell 2661.78% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 2661.78%. This contributed to the annual value of -$1.4 billion for FY2024, which is 14186.07% down from last year.
- As of Q3 2025, Crinetics Pharmaceuticals' Enterprise Value stood at -$1.1 billion, which was down 2661.78% from -$2.3 billion recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Enterprise Value ranged from a high of -$150.7 million in Q1 2021 and a low of -$2.5 billion during Q1 2025
- Its 5-year average for Enterprise Value is -$730.8 million, with a median of -$408.5 million in 2022.
- Per our database at Business Quant, Crinetics Pharmaceuticals' Enterprise Value skyrocketed by 3524.48% in 2023 and then plummeted by 22622.25% in 2024.
- Crinetics Pharmaceuticals' Enterprise Value (Quarter) stood at -$334.2 million in 2021, then decreased by 0.45% to -$335.7 million in 2022, then crashed by 66.76% to -$559.9 million in 2023, then plummeted by 141.86% to -$1.4 billion in 2024, then rose by 19.33% to -$1.1 billion in 2025.
- Its Enterprise Value was -$1.1 billion in Q3 2025, compared to -$2.3 billion in Q2 2025 and -$2.5 billion in Q1 2025.